Arca Biopharma (ABIO) is a biopharmaceutical company. Arca Biopharma's principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. This stock is trading up 5.5% at 36 cents per share in recent trading.
Today's Range: $0.32-$0.3652-Week Range: $0.31-$2.45 Volume: 119,000 Three-Month Average Volume: 91,008 >>5 Rocket Stocks Worth Buying This Week From a technical perspective, ABIO is ripping to the upside here right off some near-term support at 31 cents per share with above average volume. This move has also pushed ABIO above some near-term overhead resistance at 35 cents per share. Traders should now look for long-biased trades as long as ABIO is trending above 35 cents with strong upside volume flows. I would consider any upside volume day that registers near or above 91,008 shares as bullish. If ABIO can maintain that trend, then this stock has a great chance of re-testing and possibly taking out its next major overhead resistance levels at 40 cents to 47 cents per share.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV